Treatment with anti-IL-6 or anti-IL-6 receptor antibodies reduces PD-L1 expression patient-derived xenografts, which indicates that tumor-induced peripheral immunosuppression promotes brain metastases [19]. This evidence concerns the gene CD274 and neoplasm.